PRIVATE CLUB LAUNCHES JUVENILE DIABETES GOLF FUNDRAISER
Inspired by Children of Members and Employees with Type 1 Diabetes
FOR IMMEDIATE RELEASE
Contact: Damon DeVito - (434) 817-4570 or firstname.lastname@example.org
ROUND HILL, VA – October 25, 2011 –Stoneleigh Golf & Country Club last week launched an inaugural golf outing to fund juvenile diabetes research. Net proceeds from the tournament were donated to the Juvenile Diabetes Research Foundation which seeks ways to prevent, treat and ultimately cure type 1 diabetes.
Area sports teams supported the event with auction donations including an autographed baseball by Washington Nationals outfielder Bryce Harper and a hockey game stick signed by Capitals star Alex Ovechkin.
“Stoneleigh has a long-standing tradition of giving back to the local community,” said the Club’s General Manager Bob Strohecker. “The prevention and cure of juvenile diabetes is a cause close to the heart of Stoneleigh as it has affected the families of several members and employees including my son who is one of the three million Americans affected.”
Damon DeVito of Affinity Management, which operates Stoneleigh adds, “We felt this is something we had to do. Seeing a child suffer is heartbreaking, and when it affects the families of your staff you want to be a positive force for change. We believe a cure is attainable and we’re happy to open our doors and get involved if we can make that come even one day sooner.”
Stoneleigh G&CC is a full-service golf and country club with an expansive practice facility, swimming pool, and a golf course that has been called “one of the most beautiful and accessible golf courses in Northern Virginia.” Stoneleigh hosts outings, special events and weddings and offers mountain vistas and enclosed pre-Civil War era stonewall courtyard. For more information about Stoneleigh G&CC, visit www.stoneleighgolf.com or call (540) 338-4653.
JDRF (www.jdrf.org) is the largest charitable supporter of type 1 diabetes (T1D) research. The goal of JDRF is to accelerate progress on the most promising opportunities for curing, treating and preventing T1D. Since its founding in 1970, JDRF has awarded more than $1.5 billion to T1D research.